Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
Crossref DOI link: https://doi.org/10.1007/s11523-015-0372-y
Published Online: 2015-06-03
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liffers, Katrin
Kolbe, Katarina
Westphal, Manfred
Lamszus, Katrin
Schulte, Alexander
Text and Data Mining valid from 2015-06-03